Quantum-Si (QSI) Preferred Stock Liabilities (2020 - 2021)
Quantum-Si (QSI) posted quarterly Preferred Stock Liabilities of $195.8 million for Q1 2021, little changed quarter-over-quarter from $195.8 million in Q4 2020.
Quantum-Si (QSI) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
Quantum-Si (QSI) has reported Preferred Stock Liabilities for 2 consecutive years, with $195.8 million the latest figure, recorded in Q1 2021.
- In Q1 2021, Preferred Stock Liabilities changed N/A year-over-year to $195.8 million; the TTM figure through Mar 2021 stood at $195.8 million (changed N/A YoY), while the FY2020 annual figure was $195.8 million, up 21.96% from the prior year.
- Preferred Stock Liabilities held at $195.8 million in Q1 2021 per QSI's latest filing, from $195.8 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $195.8 million in Q4 2020 and bottomed at $170.8 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Quantum-Si | 170.21 Mn | 170.21 Mn | 172,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 195.81 Mn |
| Dec 31, 2020 | 195.81 Mn |
| Sep 30, 2020 | 170.83 Mn |
| Jun 30, 2020 | 170.83 Mn |